BIOLINERX LTD. AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • January 21st, 2021 • BioLineRx Ltd. • Pharmaceutical preparations • New York
UNDERWRITER WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES BIOLINERX LTD.Underwriter Warrant Agreement • January 21st, 2021 • BioLineRx Ltd. • Pharmaceutical preparations • New York
THIS UNDERWRITER WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 22, 2021 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January 19, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BIOLINERX LTD., a company organized under the laws of the State of Israel (the “Company”), up to [Ÿ] Ordinary Shares, par value NIS 0.10 per share, of the Company (the “Warrant Shares”) represented by [Ÿ] American Depositary Shares (each, an “ADS” and, collectively, the “ADSs” and the ADSs issuable upon exercise of this Warrant, the “Warrant ADSs”), as subject to adjustment hereunder. The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant
